期刊文献+

子宫颈腺癌人乳头状瘤病毒感染与型别分布研究中应注意的问题 被引量:2

Human papillomavirus infection and genotype distribution in cervical adenocarcinoma: problems should be noticed
原文传递
导出
摘要 子宫颈癌是女性常见的恶性肿瘤之一。在过去的几十年中,以细胞学为基础的筛查已大大降低了一些国家子宫颈鳞状细胞癌的发病率。但是,子宫颈腺癌的绝对和相对发病率在全世界范围内有所增高,即使在成功开展了子宫颈癌筛查的国家之中,其腺癌发病率也呈现出上升趋势。这种变化趋势使得腺癌成为子宫颈癌预防的焦点之一,同时也提示以细胞学为基础的常规筛查并不能有效预防子宫颈腺癌。人乳头状瘤病毒(HPV)是子宫颈腺癌的一个重要的致病因素,因此,以HPV DNA为基础的筛查和子宫颈癌疫苗能有效预防子宫颈腺癌的发生。但是,这些措施的实施和评价有赖于腺癌中HPV感染率和型别分布的可靠数据。文章综述了目前关于子宫颈腺癌HPV感染和型别分布研究所存在的问题及相应的解决方法。 ervical cancer is one of the most common cancer in women worldwide. The incidence of squamous cell carcinoma(SCC) has decreased significantly in countries with cervical cancer screening programs over the past decades. However, an increasing of both absolute and relative incidence of cervical adenocarcinoma(CADC) has been observed worldwide, including countries where screening is routinely implemented, indicating that conventional screening programs can't offer adequate protection against CADC. Since human papillomavirus (HPV) is an important etiologic factor of CADC, CADC may be effectively prevented by prophylactic vaccine and screening based on HPV DNA test. But it needs reliable data of HPV infection and genotype distribution in CADC to assess the potential benefits of vaccination and screening based on HPV DNA test. This review summarizes the problems in researches regarding to HPV infection and genotype distribution in CADC and finds out the solutions.
出处 《肿瘤研究与临床》 CAS 2013年第7期502-504,共3页 Cancer Research and Clinic
关键词 子宫颈肿瘤 腺癌 人乳头状瘤病毒 基因型别 Uterine cervical neoplasms Adenocarcinoma Human papillomavirus Genotype
  • 相关文献

参考文献29

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61: 69-90.
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin, 2012, 62: 10-29.
  • 3Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine, 2006, 24 (Suppl 3): S11-25.
  • 4Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine, 2008, 26(Suppl 10): K1- 16.
  • 5Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer, 2011,128: 927-935.
  • 6Wang SS, Carreon JD, Gomez SL, et al. Cervical cancer incidence among 6 Asian ethnic groups in the United States, 1996 through 2004. Cancer, 2010, 116: 949-956.
  • 7Bray F, Carstensen B, M-ller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prey, 2005, 14: 2191-2199.
  • 8Vizcaino AP, Moreno V, Bosch FX, et al. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer, 1998, 75: 536-545.
  • 9Liu S, Semeneiw R, Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ. 2001. 164: 1151-1152.
  • 10Smith HO, Tiffany MF, Quails CR, et al. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study. Gynecol Oncol, 2000, 78: 97-105.

二级参考文献26

  • 1刘月香,王全红,常芳.液基细胞学诊断子宫颈病变的价值[J].肿瘤研究与临床,2008,20(1):46-47. 被引量:1
  • 2郑曙民,陈星,籍海红,王慧.子宫颈癌患者人乳头瘤病毒16、18检测[J].肿瘤研究与临床,2008,20(1):48-49. 被引量:3
  • 3郎景和.子宫颈病变防治的几个问题[J].世界医学杂志,2004,8(11):1-3. 被引量:84
  • 4何桂蓉,刘忠.高危型HPV型别、病毒载量与宫颈癌前病变的相关性研究[J].现代检验医学杂志,2007,22(4):32-35. 被引量:22
  • 5Ferlay J, Shin H, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [EB/OL]. Lyon, France:International Agency for Research on Cancer, 2010.
  • 6de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology, 2004, 324: 17-27.
  • 7Zur HH. Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta, 1996, 1288: F55-F78.
  • 8Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 2003, 88: 63-73.
  • 9La KW, Cheung TH, Chung TK, et al. Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers. Gyneeol Obstet Invest, 2001, 5 l: 202-207.
  • 10Skyldberg BM, Murray E, Lambkin H, et al. Adenocareinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations. Mod Pathol, 1999, 12: 675-682.

共引文献11

同被引文献30

  • 1李素红,王全红.HPV与宫颈癌的研究进展[J].肿瘤研究与临床,2005,17(6):430-432. 被引量:21
  • 2赵平,陈万青.2008中国肿瘤登记年报[M].北京:军事医学科学出版社.2009.13—17.
  • 3赫捷,赵平,陈万青.2011年中国肿瘤登记年报[M].北京:军事医学科学出版社,2012.
  • 4Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61: 69-90.
  • 5Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CA Cancer J Clin, 2012, 62: 10-29.
  • 6The Lancet, Women's health in rural China[J]. Lancet, 2009, 374: 358.
  • 7Adams M, Jasani B, Fiander A. Human papillomavirus (HPV) prophylactic vaccination: challenges for public health and implications for screening[J]. Vaccine, 2007, 25: 3007-3013.
  • 8Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication[J]. Int J Cancer, 2011, 128: 927-935.
  • 9Paavonen J, Naud P, Salmer6 n J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infeetion and precancer caused by oncogenie HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women[J]. Lancet, 2009, 374:301-314.
  • 10Ault KA. Future II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-partiele vaccine on risk of cervical intraepitbelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials[J]. Lancet, 2007, 369: 1861-1868.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部